Surgical Innovation Associates Raises $15 Million in Oversubscribed Series B Round, Appoints Veteran Medtech CEO
Retrieved on:
Thursday, December 16, 2021
Biotechnology, Health, Surgery, Medical Devices, History of the Georgia Institute of Technology, Weakness, FDA, MIT, Central nervous system, Northwestern Memorial Hospital, MIT Sloan School of Management, Beth Israel Deaconess Medical Center, PHP, Chemical engineering, S.A, Growth, III, Wound healing, Medtronic, Medical college, Acquisition, General surgery, LLC, Pharmacokinetics, Baxter International, CEO, Sulfoxide, Leadership, Health care, CE, BS, Federal Food, Drug, and Cosmetic Act, Pioneer, Surgeon, MBA, Use, MD, Warning, Ideation, Medical College of Georgia, Technology, PEAK, 3D printing, Pharmaceutical industry, Medical device, Management, EU, LP, Allergan, Surgical Innovation Associates (SIA), Pioneer Healthcare Partners, LP, SURGICAL INNOVATION ASSOCIATES (SIA), PIONEER HEALTHCARE PARTNERS, LP
Pioneer Healthcare Partners, LP, led the $15 Million financing, which was oversubscribed.
Key Points:
- Pioneer Healthcare Partners, LP, led the $15 Million financing, which was oversubscribed.
- Participants included both new and existing investors, as well as current board members, who have collectively infused more than $20 million since the companys founding in 2016.
- Dr. Mlodinow, the founding CEO of SIA, began his plastic and reconstructive surgery residency at Northwestern Memorial Hospital in June, 2021.
- This Series B round sets the stage for us to expand our efforts to raise the standard of care in surgery.